MedTrace Logo

Left Atrial Appendage Electrical Isolation in Persistent Atrial Fibrillation

NCT04897204 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2021-05-21

No results posted yet for this study

Summary

This project intends to enroll patients with persistent atrial fibrillation who are planning to undergo catheter ablation of atrial fibrillation. The two groups of patients were routinely performed atrial fibrillation pulmonary vein isolation and linear ablation with left atrial appendage occlusion. The experimental group received additional left atrial appendage electrical isolation before the left atrial appendage occlusion, and the control group did not perform left atrial appendage electrical isolation. We are intend to evaluate the safety and effectiveness of one-stop operation of left atrial appendage electrical isolation combined with left atrial appendage occlusion in the treatment of persistent atrial fibrillation.

Conditions

Interventions

PROCEDURE

Catheter ablation and left atrial appendage occlusion

The patients underwent routine pulmonary vein isolation and linear ablation and left atrial appendage occlusion.

PROCEDURE

Additional left atrial appendage electrical isolation combined with catheter ablation and left atrial appendage occlusion

These patients underwent routine pulmonary vein isolation and linear ablation and left atrial appendage occlusion, combined with additional left atrial appendage occlusion.

Sponsors & Collaborators

  • ZHONGNANSHAN MEDICAL FOUNDATION OF GUANGDONG PROVINCE

    collaborator UNKNOWN

  • Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-01
Primary Completion
2022-12-31
Completion
2022-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04897204 on ClinicalTrials.gov